ADS201844-SD: Baxter Floseal Hemostatic Matrix Fast Prep 5ml

Sign in to add this product to your favorites!
| Price: | $349.99 per kit |
|---|---|
| Quantity: | |
| In Stock: | 12 kits |
| Expiration: | 01-2027 |
| Express: | Need it tomorrow? Order in next 15 hours 2 minutes and choose overnight shipping at checkout. |
Related Items
0600225-SD $99.99 per box of 6 Baxter Endoscopic Applicator 41cm In-Date Out of Stock |
ADS202110-SD $349.99 per kit Baxter Floseal Hemostatic Matrix w/RECOTHROM 10ml Exp: 03-2027 Units in stock: 36 kits | Order Qty |
0600225-SD $14.99 EACH Baxter Endoscopic Applicator 41cm In-Date Out of Stock |
1504516-SD $427.99 per kit Baxter Tisseel Fibrin Sealant with Duploject System 10ml (EXPIRES 12/31/26) Exp: 12-2026 Units in stock: 3 kits | Order Qty |
Additional Details
Baxter Floseal Hemostatic Matrix
Baxter Floseal Hemostatic Matrix Fast Prep 5ml
Product Code: ADS201844
Additional Details
- Company Name: Baxter Healthcare Corporation
- FDA Product Code: PMX
- FDA Product Code Name: Absorbable collagen hemostatic agent with thrombin
- GMDN Term Code: 47201
- GMDN Term Name: Collagen haemostatic agent, non-antimicrobial
- GMDN Term Definition: A bioabsorbable device derived from animal collagen (e.g., bovine or porcine collagen) designed to produce a rapid haemostasis through platelet activation/aggregation (which initiates the haemostatic cascade leading to a fibrin clot) during a surgical procedure. It is applied directly to the wound where it remains to be absorbed by the body; it is not dedicated to a specific anatomy/application and does not contain an antimicrobial agent. It may be supplied as a fibrillar or soft, pliable pad/sponge or loose fibres; it may be applied in combination with fibrin adhesives. This is a single-use device.
AccessGUDID Info
- FDA Product Code: PMX
- FDA Product Code Name: Absorbable collagen hemostatic agent with thrombin
- GMDN Term Code: 47201
- GMDN Term Name: Collagen haemostatic agent, non-antimicrobial
- GMDN Term Description: A bioabsorbable device derived from animal collagen (e.g., bovine or porcine collagen) designed to produce a rapid haemostasis through platelet activation/aggregation (which initiates the haemostatic cascade leading to a fibrin clot) during a surgical procedure. It is applied directly to the wound where it remains to be absorbed by the body; it is not dedicated to a specific anatomy/application and does not contain an antimicrobial agent. It may be supplied as a fibrillar or soft, pliable pad/sponge or loose fibres; it may be applied in combination with fibrin adhesives. This is a single-use device.
Manufacturer
Baxter provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
IN-DATE